192 related articles for article (PubMed ID: 15265162)
1. Treatment of osteopenia and osteoporosis in renal transplant children and adolescents.
El-Husseini AA; El-Agroudy AE; El-Sayed MF; Sobh MA; Ghoneim MA
Pediatr Transplant; 2004 Aug; 8(4):357-61. PubMed ID: 15265162
[TBL] [Abstract][Full Text] [Related]
2. Treatment of renal transplant recipients with low bone mineral density: a randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol.
Trabulus S; Altiparmak MR; Apaydin S; Serdengecti K; Sariyar M
Transplant Proc; 2008; 40(1):160-6. PubMed ID: 18261575
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized study for prevention of postrenal transplantation bone loss.
El-Agroudy AE; El-Husseini AA; El-Sayed M; Mohsen T; Ghoneim MA
Kidney Int; 2005 May; 67(5):2039-45. PubMed ID: 15840055
[TBL] [Abstract][Full Text] [Related]
4. Preventing bone loss in renal transplant recipients with vitamin D.
El-Agroudy AE; El-Husseini AA; El-Sayed M; Ghoneim MA
J Am Soc Nephrol; 2003 Nov; 14(11):2975-9. PubMed ID: 14569109
[TBL] [Abstract][Full Text] [Related]
5. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
Spiechowicz U; Kokot F; Wiecek A
Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents.
El-Husseini AA; El-Agroudy AE; El-Sayed M; Sobh MA; Ghoneim MA
Am J Transplant; 2004 Dec; 4(12):2052-7. PubMed ID: 15575909
[TBL] [Abstract][Full Text] [Related]
7. Alendronate prevents further bone loss in renal transplant recipients.
Giannini S; D'Angelo A; Carraro G; Nobile M; Rigotti P; Bonfante L; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
J Bone Miner Res; 2001 Nov; 16(11):2111-7. PubMed ID: 11697808
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
9. Treatment of osteopenia and osteoporosis after kidney transplantation.
Grotz WH; Rump LC; Niessen A; Schmidt-Gayk H; Reichelt A; Kirste G; Olschewski M; Schollmeyer PJ
Transplantation; 1998 Oct; 66(8):1004-8. PubMed ID: 9808483
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in live related kidney transplant children and adolescents.
el-Husseini AA; el-Agroudy AE; Wafa EW; Mohsen T; Sobh MA; Ghoneim MA
Int Urol Nephrol; 2004; 36(1):95-100. PubMed ID: 15338684
[TBL] [Abstract][Full Text] [Related]
12. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure.
Rix M; Eskildsen P; Olgaard K
Nephrol Dial Transplant; 2004 Apr; 19(4):870-6. PubMed ID: 15031343
[TBL] [Abstract][Full Text] [Related]
13. [Bone metabolism as assessed with selected markers of bone turnover as well as densitometry analysis in patients after successful kidney transplantation].
Giza D; Stompór T; Katra B; Sieradzki J; Sułowicz W
Przegl Lek; 2001; 58(11):979-84. PubMed ID: 11987839
[TBL] [Abstract][Full Text] [Related]
14. Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation.
Omidvar B; Ghorbani A; Shahbazian H; Beladi Mousavi SS; Shariat Nabavi SJ; Alasti M
Iran J Kidney Dis; 2011 Nov; 5(6):420-4. PubMed ID: 22057076
[TBL] [Abstract][Full Text] [Related]
15. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.
Cruz DN; Wysolmerski JJ; Brickel HM; Gundberg CG; Simpson CA; Mitnick MA; Kliger AS; Lorber MI; Basadonna GP; Friedman AL; Insogna KL; Bia MJ
Transplantation; 2001 Jul; 72(1):83-8. PubMed ID: 11468539
[TBL] [Abstract][Full Text] [Related]
16. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
[TBL] [Abstract][Full Text] [Related]
17. Comparison of calcium and alfacalcidol supplement in the prevention of osteopenia after kidney transplantation.
Berczi C; Asztalos L; Kincses Z; Balogh A; Löcsey L; Balázs G; Lukács G
Osteoporos Int; 2003 Jun; 14(5):412-7. PubMed ID: 12730763
[TBL] [Abstract][Full Text] [Related]
18. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
19. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
Bianda T; Linka A; Junga G; Brunner H; Steinert H; Kiowski W; Schmid C
Calcif Tissue Int; 2000 Aug; 67(2):116-21. PubMed ID: 10920215
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation.
Nowacka-Cieciura E; Cieciura T; Baczkowska T; Kozińska-Przybył O; Tronina O; Chudziński W; Pacholczyk M; Durlik M
Transplant Proc; 2006; 38(1):165-7. PubMed ID: 16504693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
